501 related articles for article (PubMed ID: 14584272)
1. [Chemotherapy cancer treatment during the past sixty years].
Furue H
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1404-11. PubMed ID: 14584272
[TBL] [Abstract][Full Text] [Related]
2. Curative cancer chemotherapy.
Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
[TBL] [Abstract][Full Text] [Related]
3. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
Hudis CA; Winer EP
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
[TBL] [Abstract][Full Text] [Related]
4. Principles of current cancer chemotherapy.
Wiemann MC; Calabresi P
Compr Ther; 1983 Mar; 9(3):46-52. PubMed ID: 6839689
[TBL] [Abstract][Full Text] [Related]
5. [Cancer chemotherapy today and in the future].
Tanneberger S
Z Gesamte Inn Med; 1990 Dec; 45(23):693-5. PubMed ID: 2102024
[TBL] [Abstract][Full Text] [Related]
6. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
[TBL] [Abstract][Full Text] [Related]
7. Cancer clinical trials: the emergence and development of a new style of practice.
Keating P; Cambrosio A
Bull Hist Med; 2007; 81(1):197-223. PubMed ID: 17369668
[TBL] [Abstract][Full Text] [Related]
8. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
Medina PJ; Goodin S
Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
10. The historical development of cancer chemotherapy.
Burchenal JH
Semin Oncol; 1977 Jun; 4(2):135-46. PubMed ID: 327552
[No Abstract] [Full Text] [Related]
11. [Palliative tumor chemotherapy and quality of life: what is optimal?].
Brunner KW
Schweiz Med Wochenschr; 1987 May; 117(18):688-92. PubMed ID: 2438763
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of cancer chemotherapy.
Alnaim L
J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
[TBL] [Abstract][Full Text] [Related]
13. The importance of chemotherapy dose intensity in lung cancer.
Crawford J
Semin Oncol; 2004 Dec; 31(6 Suppl 15):25-31. PubMed ID: 15726536
[TBL] [Abstract][Full Text] [Related]
14. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review).
Boulikas T; Vougiouka M
Oncol Rep; 2004 Mar; 11(3):559-95. PubMed ID: 14767508
[TBL] [Abstract][Full Text] [Related]
15. The evolution of curative cancer therapy.
Frei E
Mt Sinai J Med; 1992 Oct; 59(5):408-11. PubMed ID: 1435837
[No Abstract] [Full Text] [Related]
16. [Clinicopathological characteristics of gastric cancer in elderly patients].
Boku N; Okamoto R; Kandabashi K; Sasaki E; Omuro Y; Maeda Y; Sasaki T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1099-103. PubMed ID: 16912528
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
Buijs C; Rodenhuis S; Seynaeve CM; van Hoesel QG; van der Wall E; Smit WJ; Nooij MA; Voest E; Hupperets P; TenVergert EM; van Tinteren H; Willemse PH; Mourits MJ; Aaronson NK; Post WJ; de Vries EG
J Clin Oncol; 2007 Dec; 25(34):5403-9. PubMed ID: 18048822
[TBL] [Abstract][Full Text] [Related]
18. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
Budman DR
Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
[TBL] [Abstract][Full Text] [Related]
19. Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer.
Shimizu C; Ando M; Kouno T; Katsumata N; Fujiwara Y
Jpn J Clin Oncol; 2007 Jan; 37(1):1-8. PubMed ID: 17202251
[TBL] [Abstract][Full Text] [Related]
20. A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma.
Eisenberger MA; Bezerdjian L; Kalash S
Urol Clin North Am; 1987 Nov; 14(4):695-706. PubMed ID: 3314063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
